Cargando…
Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep)
PURPOSE: To evaluate the pharmacology and toxicology of SAF312, a transient receptor potential vanilloid 1 (TRPV1) antagonist. METHODS: TRPV1 expression in human ocular tissues was evaluated with immunohistochemistry. Inhibition of calcium influx in Chinese hamster ovary (CHO) cells expressing human...
Autores principales: | Mogi, Muneto, Mendonza, Anisha E., Chastain, James, Demirs, John T., Medley, Quintus G., Zhang, Qin, Papillon, Julien P. N., Yang, Junzheng, Gao, Yan, Xu, YongYao, Stasi, Kalliopi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484039/ https://www.ncbi.nlm.nih.gov/pubmed/37672251 http://dx.doi.org/10.1167/tvst.12.9.5 |
Ejemplares similares
-
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) for Postoperative Pain After Photorefractive Keratectomy
por: Thompson, Vance, et al.
Publicado: (2023) -
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy Participants
por: Stasi, Kalliopi, et al.
Publicado: (2022) -
Accurate In Vivo Bowman's Thickness Measurement Using Mirau Ultrahigh Axial Resolution Line Field Optical Coherence Tomography
por: Lawman, Samuel, et al.
Publicado: (2022) -
Titanium Powder 3D-Printing Technology for a Novel Keratoprosthesis in Alkali-Burned Rabbits
por: Magalhães, Otavio de Azevedo, et al.
Publicado: (2022) -
Sustained Release of Tacrolimus From a Topical Drug Delivery System Promotes Corneal Reinnervation
por: Daeschler, Simeon C., et al.
Publicado: (2022)